Clinical Trials Logo

Retinitis Pigmentosa 39 clinical trials

View clinical trials related to Retinitis Pigmentosa 39.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT03146078 Active, not recruiting - Clinical trials for Usher Syndrome, Type 2A

Rate of Progression in USH2A-related Retinal Degeneration

RUSH2A
Start date: August 11, 2017
Phase:
Study type: Observational

The overall goal of this project funded by the Foundation Fighting Blindness is to characterize the natural history of disease progression in patients with USH2A related retinal degeneration associated with congenital hearing loss (Usher syndrome type 2a) or non-syndromic retinitis pigmentosa (RP39).